Using Micro Air nebulizers and vibration mesh technology (NE-U07, Omron, Tokyo, Japan), patients receiving NAC combined with pirfenidone were treated twice daily with 352.4 mg of inhaled NAC, which wa
Sponsors
Grant for Research on Diffuse Lung Disease from the Ministry of Health, Labour and Welfare of Japan., Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo,
Conditions
Idiopathic pulmonary fibrosis
Unknown Phase
A prospective randomized, multicenter trial evaluating the efficacy and safety of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis.
Active, not recruitingJPRN-UMIN000015508
Start: 2015-01-01Target: 150Updated: 2026-06-29
A case-control study evaluating the efficacy and safety of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis.
Active, not recruitingJPRN-UMIN000016045
Start: 2009-10-03Target: 20Updated: 2026-06-29